Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iridex (IRIX) Common Equity (2016 - 2025)

Historic Common Equity for Iridex (IRIX) over the last 17 years, with Q3 2025 value amounting to $4.7 million.

  • Iridex's Common Equity rose 7845.98% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.7 million, marking a year-over-year increase of 7845.98%. This contributed to the annual value of $2.1 million for FY2024, which is 7797.73% down from last year.
  • Per Iridex's latest filing, its Common Equity stood at $4.7 million for Q3 2025, which was up 7845.98% from $6.1 million recorded in Q2 2025.
  • Iridex's 5-year Common Equity high stood at $26.9 million for Q3 2021, and its period low was $852000.0 during Q1 2025.
  • For the 5-year period, Iridex's Common Equity averaged around $13.6 million, with its median value being $14.7 million (2023).
  • Within the past 5 years, the most significant YoY rise in Iridex's Common Equity was 7845.98% (2025), while the steepest drop was 8686.81% (2025).
  • Over the past 5 years, Iridex's Common Equity (Quarter) stood at $25.3 million in 2021, then plummeted by 31.95% to $17.2 million in 2022, then plummeted by 44.74% to $9.5 million in 2023, then plummeted by 77.98% to $2.1 million in 2024, then soared by 123.22% to $4.7 million in 2025.
  • Its last three reported values are $4.7 million in Q3 2025, $6.1 million for Q2 2025, and $852000.0 during Q1 2025.